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Abstract
Background: Maternal mortality ratio is 276 per 100,000 live births in Pakistan. Eclampsia is responsible for one in
every ten maternal deaths despite the fact that management of this disease is inexpensive and has been available
for decades. Many studies have shown that health care providers in low and middle-income countries have limited
training to manage patients with eclampsia. Hence, we aimed to explore the knowledge of different cadres of
health care providers regarding aetiology, diagnosis and treatment of pre-eclampsia and eclampsia and current
management practices.
Methods: We conducted a mixed method study in the districts of Hyderabad and Matiari in Sindh province,
Pakistan. Focus group discussions and interviews were conducted with community health care providers, which
included Lady Health Workers and their supervisors; traditional birth attendants and facility care providers. In total
seven focus groups and 26 interviews were conducted. NVivo 10 was used for analysis and emerging themes and
sub-themes were drawn.
Results: All participants were providing care for pregnant women for more than a decade except one traditional
birth attendant and two doctors. The most common cause of pre-eclampsia mentioned by community health care
providers was stress of daily life: the burden of care giving, physical workload, short birth spacing and financial
constraints. All health care provider groups except traditional birth attendants correctly identified the signs,
symptoms, and complications of pre-eclampsia and eclampsia and were referring such women to tertiary health
facilities. Only doctors were aware that magnesium sulphate is recommended for eclampsia management and
prevention; however, they expressed fears regarding its use at first and secondary level health facilities.
Conclusion: This study found several gaps in knowledge regarding aetiology, diagnosis and treatment of
pre-eclampsia among health care providers in Sindh. Findings suggest that lesser knowledge regarding
management of pre-eclampsia is due to lack of refresher trainings and written guidelines for management of
pre-eclampsia and presentation of fewer pre-eclamptic patients at first and secondary level health care facilities.
We suggest to include management of pre-eclampsia in regular trainings of health care providers and to provide
management protocols at all health facilities.
Trial registration: NCT01911494
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Plain english summary
High blood pressure in pregnancy is one of the major
three causes of maternal deaths in Pakistan. Different re-
search studies have shown that health care providers have
limited knowledge regarding management of these pa-
tients. In this study we explored knowledge of community
and hospital based health care providers regarding causes,
complications and treatment of the disease. Doctors, Lady
Health Workers, Lady Health Supervisors and traditional
birth attendants were interviewed in groups and one to
one in Sindh province. Along with interviews Lady Health
Workers were also asked to fill a questionnaire to assess
their competency and knowledge. Study found that com-
munity based health care providers consider stress and
physical work load a cause of high blood pressure. Only
doctors were aware of the first line medicine to treat
severe cases of high blood pressure in pregnancy but they
were concerned regarding the safety of drug to be used in
small health facilities. Regular trainings of care providers
are required to improve their knowledge and practices to
deal with pregnant women with high blood pressure.
Background
Pre-eclampsia is defined as development of new hyperten-
sion in pregnancy along with significant proteinuria occur-
ring after 20 weeks of gestation [1]. It is a multisystem
disorder that may affect the liver, kidney and clotting in
pregnancy, as well as potential fetal growth restriction and
premature delivery [1]. Eclampsia is a complication of
pre-eclampsia defined as the new onset of grand mal
seizure(s) and/or unexplained coma during pregnancy or
postpartum in a woman with pre-eclampsia [2]. Eclampsia
is responsible for one in ten maternal deaths, and claims
2000 maternal lives every year, in Pakistan [3, 4].
Several multicounty trials [5, 6] and systematic reviews
[7] have proved that MgSO4 is an important agent in the
management of severe pre-eclampsia and eclampsia. The
World Health Organization (WHO) stated that MgSO4
is the first line drug for treatment of pre-eclampsia and
eclampsia more than a decade ago [8] and Pakistan in-
cluded MgSO4 in the national essential drug list in 2007
[9]. However, these efforts have not translated into prac-
tice and a large number of women continue to suffer
from pre-eclampsia and eclampsia without receiving life-
saving treatment.
In Pakistan, the health care system is comprised of
both formal and informal sectors. Formal system in-
cluded public and private health facilities. Pakistan’s
public health system is centralised under the Federal
Government and Provincial Health Ministries; and com-
prises of primary, secondary and tertiary health centres.
Primary care facilities include 5000 Basic Health Units,
560 Rural Health Centres, 900 Maternal and Child
Health centres and large number of dispensaries and
first aid posts. Secondary level centres include 900
Taluka and district level hospitals. Tertiary health care is
delivered through 30 teaching hospitals [10].
Lady Health Workers (LHWs) and Lady Health
Visitors (LHVs) are deployed as community-based health
care workers in the home and primary health centres
[10]. Doctors and nurses are deployed at all levels of
health care facilities. The private sector consists of a few
accredited tertiary level hospitals and a large number of
non-accredited tertiary, secondary and primary clinics
and hospitals both in urban and rural areas. The infor-
mal health care system is led by non-certified local
health care providers, such as traditional birth atten-
dants (TBA), spiritual healers, and Hakeems (practitioner
of Unani/Greek medicine). The informal health care sys-
tem is patronised by many as treatment is affordable,
available within the local community, and in-line with
traditional and cultural beliefs [11].
Studies from other low and middle-income countries
(LMIC) reported that contrary to WHO guidelines, women
were not regularly screened for high blood pressure during
antenatal care [12]. Literature from the developing world
has also reported that various cadres of health care
providers (doctors, nurses, midwife, and community care
providers) have limited knowledge regarding screening and
management of pre-eclampsia [13–15].
The limited knowledge of health care providers likely
plays a role in the slow reduction in maternal morbidity
and mortality due to pre-eclampsia in developing
countries, such as Pakistan. Hence, we explored the know-
ledge of different health care providers regarding pre-
eclampsia and eclampsia and their current management
practices in rural Sindh, Pakistan.
Study area
This study was conducted in Matiari and Hyderabad,
which are two districts of Sindh province. Sindhi is the
most common language of both districts. Hyderabad has
a population of 4.5 million of which 60 % live in urban
areas, it is second most urbanised district of Sindh after
Karachi [16]. Matiari district is located 250 km north of
Karachi, with a population of 0.6 million. The area is
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largely agricultural and development indicators are
representative of rural Sindh [17] (Table 1).
Methods
The Community Level Intervention for Pre-eclampsia
(CLIP) study is a cluster randomized trial which is being
conducted in two districts of Sindh Pakistan
(NCT01911494). Before implementation of the trial, a
feasibility study was conducted to evaluate barriers and
facilitators of providing emergency treatment in
community to women who are at high risk of severe
pre-eclampsia. Lady Health Workers were chosen to de-
liver this intervention to pregnant women as they are re-
sponsible to provide antenatal care at home in rural
areas. Intervention package includes triage and screening
of pregnant women for risk of severe PE/E, administer-
ing oral antihypertensive and MgSO4 (if required) and
referral. It was important to understand the existing
practices and knowledge of health care providers regard-
ing PE/E. We evaluated health care providers involved in
maternal care whether they were community based
(LHW, LHS, TBAs) or health facility based (Doctors).
The feasibility assessment utilized mixed methods [18].
and intervention implementation plan was modified ac-
cording to the findings of the feasibility study.
Qualitative component
The qualitative research team organised the conduct of
focus groups and interviews. Gender specific staff was
allocated with respect of local culture and tradition. Pro-
ject staff were locally recruited and trained by a senior
faculty and a social scientist with first-hand knowledge
and expertise in qualitative research. Each focus group
was conducted in the local language by one facilitator,
two note takers, an observer and all discussions were
audio-recorded. Observers documented field notes to
capture verbal and non-verbal communication in sup-
port of the documented text. In addition, the facilitators
completed a self-reflection after each session to describe
their thoughts and impressions to better contextualize
the data, as well as, to protect against self-bias. Quality
control was ensured through random observation of
focus groups by the field co-ordinator, and an audit-trail
of 20 % of transcripts. The audit-trail process included
verifying content of transcripts with audio-recordings,
and bi-weekly debriefing sessions with moderators and
transcribers. The field staff then transcribed the data in
Sindhi based on the audio recordings. The qualitative
data was analyzed in Sindhi using NVivo version 10
[QSR, Doncaster Vic, Australia] to develop the themes
and subthemes from an ethnographic approach.
The desired number of FGDs and KIIs were deter-
mined through response saturation and data collection
was stopped when data saturation was reached at each
site. Data Saturation was reached after 26 in-depth inter-
views and seven focus groups discussions. Participants
were eligible if they consented to participate in study
and were available for at least 60 min for the interview
or discussion (Table 2).
Quantitative component
Eligible participants were identified with the help of local
community health workers and research medical officers
during health facility visits. Written consent was ob-
tained from all participants prior to data collection.
A self-administered questionnaire was completed by
457 LHWs, all questions were designed using a Likert
scale (strongly disagree to strongly agreeThe knowledge
of LHWs regarding pre-eclampsia was evaluated by a set
of questions pertaining to their ability to identify danger
signs of hypertension and seizures in pregnancy. Their
current practice of referral and skills to administer drugs
were also evaluated.
This study received ethical approval from Ethics Review
Committee of Aga Khan University, Karachi, Pakistan;
National Bioethics Committee of Pakistan and Institutional
Review Board of University of British Columbia, Vancouver
Canada.
Results
Among health care providers who participated, all were
providing care to 3–5 pregnant women daily for more
than a decade, except one TBA and two doctors. Six out
of nine women medical officers (WMO) were providing
care at the primary and secondary level public health
Table 1 Comparison of population characteristics of Sindh
Province with country estimates
Population
characteristics
Provincial estimates [28] National estimates [5]
% of women received
skilled antenatal care
78 73
% of deliveries attended
by skilled birth attendant
60 52
% of population covered
by Lady Health Workers
45 [29] 65 [30]
Table 2 Health care provider interviews and focus groups













Lady Health Worker Focus
Group
7 64
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facilities. About 6 pre-eclampsia or eclampsia patients
(range 0–100 in last 12 months) were received by (WMO)
in last 12 months. TBAs did not report encountering any
women with pre-eclampsia in the last year. According to
Lady Health Supervisors (LHS) on average 3 women with
pre-eclampsia are reported to them per year by LHWs.
Knowledge regarding pre-eclampsia aetiology and
consequences
Health care providers of all cadres reported that a
normotensive woman can develop hypertension later in
pregnancy which can lead to problems for mother and
baby. Common reasons for pre-eclampsia mentioned by
community-based health care providers (LHW, LHS and
TBAs) were stress of daily life which included burden of
care giving, physical workload, short birth spacing and
financial stresses.
“She looks after the children and again she gets
pregnant. She has no such stamina (strength) to deal
with the problems and that is the reason she also gets
irritated, sometimes because of children, sometimes
because of family problems and sometimes cause is
financial problems. She starts thinking lot and her B.P
starts to rise up”. (Focus group with LHWs)
In addition, anaemia was mentioned as a risk factor by
almost all community-based health care providers. All
participant groups, except TBAs, correctly identified
complications of pre-eclampsia: antepartum haemor-
rhage, premature delivery, stroke, brain haemorrhage,
decreased fetal movements, and restricted fetal growth.
Doctors, LHWs and their supervisors were aware that
seizures occur as a consequence of hypertension. Similar
result was found through survey of LHWs where 84.5 %
(386/457) LHWs strongly agreed that seizure is a danger
sign of pregnancy and 83.6 % (382) strongly agreed for
bleeding as a danger sign. See Additional file 1: Table S2.
TBAs were not aware of other harmful effects of disease
and considered seizures to be directly related to stress
and physical weakness.
“One cause of seizures is that they are pregnant and
the other cause is that she is anemic and stressed
out.”(Interview with a TBA)
All health care providers were aware that pre-eclampsia
could result in miscarriage or death.
“When blood pressure increases firstly it is dangerous
for the mother, the mother can also die, even the baby
can die, it can affect the mother in anyway, she can
have paralysis, because of high blood pressure
paralysis can occur.” (Focus group with LHWs)
Diagnosis and referral of pre-eclampsia
Knowledge for identifying a patient with pre-eclampsia
varied greatly among different set of care providers.
Doctors were the most knowledgeable group. They were
aware that hypertension and proteinuria constitutes pre-
eclampsia and these women require regular monitoring.
“If the woman is pre-eclamptic, we will tell them to
visit us every 15 days. She should get her blood pres-
sure checked and she should take medicines on time.”
(Interview with a WMO)
Doctors working at first and second level health facil-
ity reported refering patients to tertiary facilities The
reasons for referral of these patients included limited
availability of support staff (nurses, midwives, LHVs),
monitoring equipment and medicines required to
manage severe pre-eclampsia or eclampsia.
“When she comes with eclampsia and if she is having
seizures then we refer her because in our health centre
we don’t have facility for C-section. If she is not in a
good condition and is having seizures, we try to get her
delivery done soon as possible. If she is not able to
have normal vaginal delivery then we refer her.”(Inter-
view with a WMO)
LHWs and LHSs mentioned that they refer patients to
health facilities if there are any danger signs during preg-
nancy. Pregnant women are also reportedly referred if
there is sudden increase in weight or oedema, reduced
fetal movements, vertigo or blurred vision. This finding
was supported by quantitative assessment of LHWs
where 42.9 % (96) reported receiving trainings to identify
complications in pregnancy and 51 % (233) mentioned
training to refer and manage these patients. Many
LHWs (79 %; 361) reported referring pregnant women
in their routine practice. See Additional file 1: Tables S2
and S3.
“Vomiting more than 3 months, slowly oedema starts,
headache, having fever, bleeding during pregnancy
then in that condition we refer to heath facility.”
(Focus group with LHWs)
Focus groups with TBAs revealed that the elder TBAs
were critical of orthodox medicines and vaccines, and
consider them harmful in pregnancy. Some of these
TBAs mentioned that they referred women for vertigo
or pain, but that this is due malnutrition and anaemia.
Few young TBAs participated, though they appeared to
be more aware of the serious consequences of hyperten-
sion in pregnancy and the importance of early referral in
such cases.
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“We tell them that you must go for monthly or
fortnightly check-ups to any good health facility which
is in vicinity; go there and get your check-up.” (Inter-
view with a TBA)
TBAs commonly referred pregnant women when they
consider vaginal delivery will be difficult (e.g. cephalo-
pelvic disproportion, breech presentation) or when com-
plications occur during delivery (obstructed labour, post-
partum haemorrhage, decreased fetal movements). They
also referred women for seizures; this was done because
they believed it delays descent/delivery of baby. It was
apparent from their responses that TBAs were not aware
of the signs and symptoms of pre-eclampsia, and so re-
luctant to refer patients unless safe delivery at home is
not possible,
“Bone is short or large; (delivery) path is clear or not.
Then we refuse to take case and advise them to get her
to the hospital.”
“When we see that the fetal movements have stopped
(in woman having fits), I ask the attendants to arrange
the car quickly”. (Interview with a TBA)
When referral is required, TBAs preferred private fa-
cilities because they are perceived to be better equipped.
On the other hand, LHWs referred women to nearest
health facility.
“We will tell them to take her to the nearest hospital
or clinic as soon as possible.” (Focus group with LHWs)
Management of pre-eclampsia
This study found huge gaps in the knowledge of treat-
ment for pre-eclampsia among all cadres of health care
providers. Doctors were aware of use of antihypertensive
drugs for hypertension and MgSO4 as the first line for
eclampsia but there were several misperceptions regard-
ing the use of MgSO4. The most common misconcep-
tion was fears of MgSO4 toxicity and the need for an
intensive care unit for these women. The findings
showed that doctors did not recognise the role of
MgSO4 in reducing risk of morbidity and mortality if
administered earlier. Hence patients are referred to a
higher facility untreated or diazepam was given to con-
trol seizures. Doctors also reported that there was no
guidelines available treatment of pre-eclampsia, except
one doctor who was working in a private secondary
facility.
“No (we do not use), because it (MgSO4) is not used at
dispensary level.”
“MgSO4 we don’t give here because we need a separate
doctor to manage it.”
“We monitor the blood pressure, and try to refer the
eclamptic woman to the Civil Hospital as early as
possible.” (Interview with a WMO)
All doctors except one senior doctor, with greater than
25 years of experience, expressed a desire to learn more
regarding the management of pre-eclampsia and argued
there was a need for related guidelines. Participants
stated that they infrequently encounter pre-eclampsia;
therefore, they are not confident in managing these
cases.
Among community-based health care providers the
knowledge was increasingly limited. None of the TBAs
and very few LHWs had ever heard of MgSO4. All
LHWs were aware that hypertension and seizures need
medical treatment and women should seek care at health
facility but could not name any medications which
should be given. However, 131 (28.7 %) LHWs reported
that they can measure BP and 30 (6.6 %) had a BP de-
vice. See Additional file 1: Table S3. TBAs could not
name antihypertensive medications, they could, however,
describe their appearance (shape, colour or brand logo).
TBAs mentioned that they do not treat hypertensive
women themselves nor do they prescribe any medica-
tion. However, they mentioned giving some of the medi-
cines themselves which they might have learnt over time
from interaction with doctors. In addition to medicine
low salt and low fat diet was advised by almost all TBAs
and LHWs.
“We give it (Aldomet) daily if BP is high. We advise it
twice a day or daily at night. The patient must eat
daily so that the patient’s blood pressure remains
normal.” (Interview with a TBA)
Only one TBA, who had 50 years of experience, re-
ported giving alternative or traditional medicines (phakki)
to control blood pressure.
“We give 200, 250, grams Phakki, one spoon daily
morning she is advised to take.” (Interview with a TBA)
Similar to doctors community-based providers have
seen few patients with eclampsia in their practice; there-
fore, they were willing to learn more about the condi-
tion, its risk factors, prevention and treatment.
Discussion
This study found gaps in knowledge among community
health care providers regarding causes of PE/E and its
management. Health facility based care providers were
aware of the etiology and complications of the disease
but there were misperceptions and limited knowledge
about use of Magnesium sulphate.
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Studies have reported a common community percep-
tion that seizures of eclampsia are caused by supernat-
ural forces [19] and the frequent use of herbal medicine
delays health care seeking [20]. Community based care
providers may not connect eclampsia and hypertension;
however, none claimed to believe in evil charms or
supernatural causes for the seizures and use of alternate
medicine to treat eclampsia.
Pre-eclampsia is a serious condition, but because of
the relatively low prevalence of the disease care
providers had infrequent experience with these patients.
This lack of exposure results in a reported lack of confi-
dence in dealing with these patients. Pakistan has
included current global management principles of pre-
eclampsia in skilled birth attendants and nurses trainings
[21], but in this study health care providers expressed
desire for further training as they found current
trainings insufficient. This finding is not consistent with
Bigdeli’s findings from Pakistan that health care
providers were satisfied with their training [14].
Data from other LMIC showed a preference for diaze-
pam in cases of eclampsia [22] but in this study only
two of the nine doctors mentioned regular use of diaze-
pam. Despite prolific myths and fears related to MgSO4,
no other drugs were preferred for treating eclampsia by
the providers interviewed. This finding is consistent with
another study on use of MgSO4 from Pakistan [14]. The
preference for MgSO4 is very encouraging as use of di-
azepam in eclampsia is harmful for both mother and
baby. Health care providers in this study commonly
reported referring women with pre-eclampsia and
eclampsia prior to the administration of lifesaving treat-
ment. Similar finding has been reported in literature
[14]. Explanations for this practice in Pakistan and else-
where were related to the misperception that MgSO4
should only be used in tertiary level facilities [23]. Other
reasons MgSO4 was not administered were the lack of
written treatment and referral protocols. The lack of
clear guidelines to manage pre-eclampsia has been re-
ported earlier as a barrier to health care provision at first
and secondary level [22].
Other studies have also found that health care pro-
viders at high level facilities had better knowledge of
pre-eclampsia [24, 25]. This might be due to more ex-
posure of such cases and the availability of written
protocols.
Strengths and limitations
Several studies have been published on barriers and fa-
cilitators to use MgSO4 in LMICs [14, 15, 26, 27]. This
study explores significant aspects of management of pre
eclampsia with respect to knowledge regarding disease,
procedural ability, preference for use of drugs and clin-
ical decision making of both skilled and unskilled care
providers. Qualitative methods gave an insight to the
misperceptions related to the condition and its treat-
ment as health care providers were free to express their
beliefs, fears and experiences. TBAs are preferred birth
attendants for many rural women so it was important to
evaluate their level of understanding for the disease. So
far literature published from Pakistan on PE/E manage-
ment only assessed practice of skilled care providers.
Limitation of the study is that it did not inquire partici-
pants about management for severe pre-eclampsia and
eclampsia separately therefore the study cannot deter-
mine the knowledge of health care providers for the
prophylactic use of MgSO4 in severe pre-eclampsia.
Future researches should explore ways to develop
educational strategy and simple tools to empower first
and second level health care providers to be able to ap-
proach obstetrical problems. This will help to expedite
referral in rural pregnant women and initiating
treatment in homes in severe cases which require urgent
management even before referral. The curriculum for
health care providers who are involved with pregnant
women in communities should be reviewed and training
should ensure acquisition of competency for dealing
with obstetrical emergencies.
Conclusion
This study reveals that even in presence of a national
policy supporting pre-eclampsia programmes, providers
lack confidence and/or competence in treating these
women. Gaps in the knowledge of aetiology, diagnosis
and treatment of pre-eclampsia among all cadres of
health care providers were seen. Findings suggest that
limited exposure to pre-eclampsia cases, the lack of
refresher trainings and no written guidelines for man-
agement of the disease are important factors leading to
inadequate knowledge. We suggest inclusion of manage-
ment of pre-eclampsia in regular training of all health
care providers and to provide management protocols at
all levels of health care. There is also need for strong
advocacy for use of MgSO4 as emergency treatment
before referral from first and secondary level health facil-
ities for the best maternal and fetal outcomes.
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